InvestorsHub Logo
Followers 0
Posts 5690
Boards Moderated 0
Alias Born 06/09/2012

Re: notbrad post# 44402

Friday, 11/06/2015 2:17:23 PM

Friday, November 06, 2015 2:17:23 PM

Post# of 704381
Really? So far NWBO is up to $767,670 per patient. How? $261mm spent on R&D from 2007-today, 300 patients enrolled in P3 and 40 in Direct P1. $261mm /340=$767,670.

The average cost per patient of a phase 3 is around $50k (includes manufacturing, CRO, trial site fees, etc).

NWBO is spending just a little more than average.

"Think for yourselves and let others enjoy the privilege to do so, too."

-Voltaire

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News